AVX-470 regulatory update

FDA granted Orphan Drug designation to AVX-470 from Avaxia to treat pediatric ulcerative colitis (UC). The oral inhibitor of tumor necrosis factor (TNF) alpha completed a Phase Ib trial in adults wit...